|Bid||27.1800 x 100|
|Ask||34.8700 x 400|
|Day's Range||30.0000 - 30.6500|
|52 Week Range||16.4400 - 32.5400|
|PE Ratio (TTM)||-129.57|
|Earnings Date||Aug 1, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||34.83|
Q3 2017 Cardiovascular Systems Inc Earnings Call
Cardiovascular Systems, Inc. today announced that the U.S. Food and Drug Administration has approved its premarket approval application supplement for a redesigned saline pump used as part of the company’s Diamondback 360® Orbital Atherectomy Systems .
Cardiovascular Systems, Inc. (CSII) reported adjusted earnings per share of 3 cents in third-quarter fiscal 2017, reflecting a massive improvement from the year-ago quarter's adjusted loss of 47 cents.